"Foscarnet" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
Descriptor ID |
D017245
|
MeSH Number(s) |
D02.241.081.018.677.250 D02.705.429.875.500
|
Concept/Terms |
Foscarnet Sodium- Foscarnet Sodium
- Sodium, Foscarnet
- Foscarnet Trisodium Salt
- Trisodium Salt, Foscarnet
- Foscarnet Sodium Hexahydrate
- Hexahydrate, Foscarnet Sodium
- Sodium Hexahydrate, Foscarnet
- Trisodium Phosphonoformate
- Phosphonoformate, Trisodium
|
Below are MeSH descriptors whose meaning is more general than "Foscarnet".
Below are MeSH descriptors whose meaning is more specific than "Foscarnet".
This graph shows the total number of publications written about "Foscarnet" by people in this website by year, and whether "Foscarnet" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1996 | 1 | 0 | 1 |
1997 | 1 | 0 | 1 |
1998 | 1 | 1 | 2 |
1999 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Foscarnet" by people in Profiles.
-
Case Report: Varicella-zoster Encephalitis with Acute Retinal Necrosis and Oculomotor Nerve Palsy. Optom Vis Sci. 2019 05; 96(5):367-371.
-
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host. Transpl Infect Dis. 2016 Oct; 18(5):785-790.
-
Acute dystonic reaction associated with foscarnet administration. Am J Ther. 2008 Mar-Apr; 15(2):184-6.
-
Optical coherence tomography of progressive outer retinal necrosis. Retina. 2007 Nov-Dec; 27(9):1313-4.
-
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation. 1999 Sep 27; 68(6):814-25.
-
Foscarnet crystal deposition and renal failure. Am J Kidney Dis. 1998 Sep; 32(3):519-20.
-
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. 1998 May 11; 158(9):957-69.
-
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir. Bone Marrow Transplant. 1997 Sep; 20(6):491-5.
-
Nephrotoxicity of antiviral therapies. Curr Opin Nephrol Hypertens. 1996 Jul; 5(4):375-9.
-
A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs. J Virol Methods. 1996 Apr 26; 58(1-2):137-43.